Great news. Is it going to move the PPS? Absolutely not because I’m not sure what will at this point. It’s great news because the more patients we can get under compassionate use, the more publicity the company gets and hopefully that leads to quicker filling of the clinical trial for mTNBC. We need more data to publish solid numbers and to finally get this Leronlimab train rolling.